KRISTEN LEAKE: Open Payments
NPI 1184175168 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 115 payments from 14 companies in 2025. Trend: 2023 $1,414 · 2024 $1,249 · 2025 $2,301
Food & beverage: $2,217Education: $84
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $525 |
| ABBVIE INC. | 32 | $523 |
| Janssen Biotech, Inc. | 17 | $337 |
| Madrigal Pharmaceuticals | 8 | $214 |
| Regeneron Healthcare Solutions, Inc. | 11 | $187 |
| Phathom Pharmaceuticals, Inc. | 9 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $90 |
| Ipsen Biopharmaceuticals, Inc | 4 | $69 |
| PFIZER INC. | 3 | $58 |
| QOL Medical, LLC | 3 | $50 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, GATTEX, DUPIXENT, RINVOQ, LINZESS, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
